Nevertheless, in other previous studies HER2-overexpression was not related to worse prognosis (19), including a recently published retrospective analysis of 200 patients with SDC and adenocarcinoma NOS treated at the MD Anderson Cancer Center. This evidence concerns the gene ERBB2 and adenocarcinoma.